Position in ROIV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$362,145
+$78,165 QoQ
Shares Held
10,233
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#313
of 494 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $27,458,740 across 28 Biotechnology names. ROIV ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,761 | $11,074,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,222 | $2,097,194 | |
| 3 | ARGX |
Argenx SE
|
1,836 | $1,703,385 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
22,421 | $1,282,929 | |
| 5 | 8,952 | $1,105,572 | |||
| 6 | EXEL |
Exelixis, Inc.
|
15,411 | $838,512 | |
| 7 | RPRX |
Royalty Pharma plc
|
14,344 | $804,267 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
9,014 | $783,767 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $362,145 | 10,233 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $283,980 | 10,252 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $217,000 | 10,000 | Shares | Other | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||